The competitive nature of the pharmaceutical industry necessitates that its multifaceted supply-chain be cost-efficient and profitable. This paper aims to ascertain the critical supply-chain financial indicators influencing pharmaceutical-supply-chain (PSC) performance, revealing its unique features and assessing these indicators’ effect on profitability.
This paper measures the PSC performance of 55 public-limited Indian pharmaceutical firms, including multinational enterprises, integrating supply-chain financial variables and SCOR KPIs through a ten-year timeline. The critical supply-chain-performance indicators (SCPIs) are identified from the measured set through factor analysis. A panel data random effect model is developed, linking these critical SCPIs and profitability to understand their significant influence on profitability.
This paper has evidenced the existence of three critical SCPIs, revealing working capital efficiency, material flow efficiency and investment efficiency. It has also proved the significant influence of these SCPIs on firms’ profitability and has brought out the importance of material flow efficiency in terms of inventory and distribution efficiency as a leading contributing factor for profitability.
This paper contributes to finding key PSC performance features and their vital role in pharmaceutical firms’ profitability. Supply-chain managers can enhance PSC’s specific performance areas to be cost-efficient and can increase the firm’s profitability.
Ab TalibM. S., & Abdul HamidA. B. (2014). Application of critical success factors in supply chain management. International Journal of Supply Chain Management, 3(1), 21–29.
2.
AhmedZ., AwanM. Z., SafdarM. Z., HasnainT., & KamranM. (2016). A nexus between working capital management and profitability: A case study of pharmaceutical sector in Pakistan. International Journal of Economics and Financial Issues, 6(3S), 153–160.
3.
Arzu AkyuzG. A., & Erman ErkanT. E. (2010). Supply chain performance measurement: A literature review. International Journal of Production Research, 48(17), 5137–5155.
4.
Association for Supply Chain Management (2014). Supply Chain Operations Reference Model: Overview of SCOR Version 11. APICS
5.
Kearney InsightA.T. (2016). India’s Pharma Supply Chain: Does the Industry Have What It Takes to Win?. A.T. Kearney, Inc.
6.
BalakrishnanK., SeshadriS., SheopuriA. & IyerA. (2007). Indian auto-component supply chain at the crossroads. Interfaces, 37(4), 310–323.
7.
BanomyongR., & SupatnN. (2011). Developing a supply chain performance tool for SMEs in Thailand. Supply Chain Management: An International Journal, 16(1), 20–31.
8.
BenitaM. B. (1999). Measuring supply chain performance. International Journal of Operations & Production Management, 19(3), 275–292.
9.
BerkP., GilbertM., HerlantM. & WalterG. (2013). Rethinking the pharma supply chain: new models for a new era. The Boston Consulting Group (BCG).
10.
BhardwajA., ChaudharyV., & BargalH. (2010). An analysis of the debt-equity structure of selected pharmaceutical firms in India. International Journal of Management Prudence, 1(2), 154–160.
11.
BhagwatR., & SharmaM. K. (2007). Performance measurement of supply chain management using the analytical hierarchy process. Production Planning and Control, 18(8), 666–680.
12.
BolineniP. (2016). The Indian pharmaceutical industry’s supply chain management strategies. Walden University Scholar Works. https://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article=3497&context…
13.
BruceM., DalyL., & TowersN. (2004). Lean or agile: A solution for supply chain management for textile and clothing industry. International Journal of Operations and Production Management, 24(2), 151–170.
14.
CameronC. A., & TrivediP. K. (2009). Microeconometrics using stata. Stata Press Publication.
15.
ChanF. T. S., & QiH. J. (2003). An innovative performance measurement method for supply chain management. Supply Chain Management: An International Journal, 8(3), 209–223.
16.
ChanF. T. S., QiH. J., ChanH. K., LauH. C. W., & IpR. W. L. (2003). A conceptual model of performance measurement for supply chains. Management Decision, 41(7), 635–642.
17.
ChandrasekaranN., & KumarS.M. (2003). Pharmaceutical supply chain challenges and best practices. CII –Institute of Logistics. www.ciilogistics.com, December2003.
18.
Chih-Yang Tsai (2017). The impact of cost structure on supply chain cash flow risk. International Journal of Production Research, 55(22), 6624–6637.
19.
DasP., & DasS. (2015). Competitiveness and its impact on research and development in Indian pharmaceutical industry. Decision, 42(3), 325–334.
20.
DasC., & JharkhariaS. (2019). “Effects of low carbon supply chain practices on environmental sustainability: An empirical study on Indian manufacturing firms”,South Asian Journal of Business Studies, 8(1), 2–25.
21.
DashM., BoseA., ShomeS., MondalS., RajakumarD. J., ShettyR., MajumdarM.G. & SenguptaD. (2015). Measuring the efficiency of marketing efforts in the Indian pharmaceutical industry using data envelopment analysis. Business Analytics & Intelligence, 3(1), 1–7.
22.
DaveA. R. (2012). Financial management as a determinant of profitability: A study of Indian pharma sector. South Asian Journal of Management, 19(1), 125–136.
23.
DeloofM. (2003). Does working capital management affect profitability of Belgian firms?Journal of Business Finance and Accounting, 3, 573–787.
24.
DesaiJ., & DesaiR. (2018). Financing decision as a determinant of firms’ performance: Indian pharmaceutical industry. SCMS Journal of Indian Management, 15(3), 20–28.
25.
DharB., & JosephR. K. (2019). The challenges, opportunities and performance of the Indian pharmaceutical industry post-TRIPS. Innovation, Economic Development, and Intellectual Property in India and China, Springer, 93–117.
26.
DwivediV. K., & PathakP. (2015). Performance of supply chain in an uncertain environment using fuzzy logic. International Journal on Design & Manufacturing Technologies, 9(2), 1–5.
27.
EnyindaC. I., OgbuehiA. O., & MbahC. H. (2018). Building pharmaceutical relationship marketing and social media impact: An empirical analysis. International Journal of Pharmaceutical and Healthcare Marketing, 12(2), 198–230.
28.
EllingerA. E., NatarajarathinamM., AdamsF. G., GrayJ. B., HofmanD. & O’MarahK. (2011). Supply chain management competency and firm financial success. International Business Logistics, 32(3), 214–226.
29.
EllramL. M., & LiuB. (2002). he financial impact of supply management. Supply Chain Management Review, 6(6), 30–37.
30.
ErbaoC. B., XiushuaiZ., & KevinL. (2015). Coordinating a supply chain under demand and cost disruptions. International Journal of Production Research, 53(12), 3735–3752.
31.
EsperT. L., DefeeC.C. & MentzerJ. T. (2010). A framework of supply chain orientation. The International Journal of Logistics Management, 21(2), 161–179.
32.
FawcettS. E., OsterhausP., MagnanG. M., BrauJ.C., & McCarterM. W. (2007). Information sharing and supply chain performance: The role of connectivity and willingness. Supply Chain Management: An International Journal, 12(5), 358–368.
33.
FieldJ. M., & MeileL.C. (2008). Supplier relations and supply chain performance in financial services processes. International Journal of Operations and Production Managemen, 19(2), 130–154.
34.
GolecJ., & VernonJ. A. (2010). Financial effects of pharmaceutical price regulation on R&D spending by EU versus US firms. Pharmacoeconomics, 28(8), 615–628.
35.
GrabowskiH. (2011). The evolution of the pharmaceutical industry over the past 50 years: A personal reflection. International Journal of the Economics of Business, 18(2), 161–176.
36.
GrosvoldJ., HoejmoseS. U. & RoehrichJ. K. (2014). Squaring the circle: Management, measurement, and performance of sustainability in supply chains. Supply Chain Management: An International Journal, 19(3), 292–305.
37.
GunasekaranA., & KobuB. (2007). Performance measures and metrics in logistics and supply chain management: a review of recent literature (1995–2004) for research and applications. International Journal of Production Research, 45(12), 2819–2840.
38.
GunasekaranA., PatelC., & McGaugheyR. E. (2004). A framework for supply chain performance measurement. International Journal of Production Economics, 87, 333–347.
39.
GunasekaranA., PatelC., & TirtirogluE. (2001). Performance measures and metrics in a supply chain environment. International Journal of Operations and Production Management, 21(1–2), 71–87.
40.
GrayG. C. (2013). The ethics of pharmaceutical research funding: A social organization approach. Journal of Law, Medicine & Ethics, 41(3), 629–634.
41.
HairJr, JosephF., BlackW. C., BabinB. J., & AndersonR. E. (2019). Multivariate data analysis (8th ed.). Cengage.
42.
HassanM., PatroD. K., TuckmanH., & WangX. (2007). Do mergers and acquisitions create shareholder wealth in the pharmaceutical industry?International Journal of Pharmaceutical and Healthcare Marketing, 1(1), 58–78.
43.
HendricksK. B., & SinghalV. R. (2005). Association between supply chain glitches and operating performance. Management Science, 51(5), 695–711.
44.
HillR.CarterG., WilliamE. & LimG. C. (2008). Principles of econometrics (3rd ed.). John Wiley & Sons Ltd
45.
HoffmannE., & LockerA. (2009). Value-based performance measurement in supply chains: A case study from the packaging industry. Production Planning and Control, 20(1), 68–81.
46.
India Brand Equity Foundation (2020). Pharmaceuticals. https://www.ibef.org/industry/pharmaceutical-india.aspx
47.
India Brand Equity Foundation (2020). Indian pharmaceuticals industry report, https://www.ibef.org/industry/pharmaceutical-india.aspx
48.
IslamR., & HossainMd. & HoqMd. & AlamMd. (2018). Impact of working capital management on corporate profitability—Empirical evidence from pharmaceutical industry of Bangladesh. International Journal of Economics and Finance, 10(9). http://doi.org/10.5539/ijef.v10n9p136
49.
JamesG., WittenD., HastieT., & TibshiraniR. (2013). An introduction to statistical learning with applications in R. Springer
50.
JihuiW., XiaofeiZ., & JianjunL. (2018). Empirical research on influencing factors of sustainable supply chain management—Evidence from Beijing, China. Sustainability, 10(5), 1595.
51.
JohnsonL. (2017). Pharmaceutical labeling improves efficiencies in a highly complex supply chain. Material Handling & Logistics. www.industryweek.com/industryweek-wire/marterial-handling-logistics
52.
JohnsonM., & TemplarS. (2011). The relationships between supply chain and firm performance: the development and testing of a unified proxy. International Journal of Physical Distribution & Logistics Management, 41(2), 88–103.
53.
KalóZ., AnnemansL., & GarrisonL. P. (2013). Differential pricing of new pharmaceuticals in lower-income European countries. Expert review of Pharmacoeconomics & outcomes research, 13(6), 735–741.
54.
KamathB. G. (2008). Intellectual capital and corporate performance in Indian pharmaceutical industry. Journal of Intellectual Capital, 9(4), 684–704.
55.
KennedyP. (2003). A guide to econometrics (5th ed.). MIT Press.
56.
KumarS., TeichmanS., & TimpernagelT. (2011). A green supply chain is a requirement for profitability. International Journal of Production Research, 50(5), 1278–1296.
57.
LaknerZ., KissA., PoppZ., ZémanZ., Máté, D., & OláhJ. (2019). From basic research to competitiveness: An econometric analysis of the global pharmaceutical sector. Sustainability, 11(11), 3125.
58.
LazaridisI. & TryfonidisD. (2006). Relationship between working capital management and profitability of listed companies in the Athens Stock Exchange. Journal of Financial Management and Analysis, 19, 26–35.
59.
LevinA., LinC.-F., & James ChuC.-S. (2002). Unit root tests in panel data: asymptotic and finite-sample properties. Journal of Econometrics, 108(1), 1–24.
60.
LiangXu, & SmithL. D. (2018). Combining traditional and value-added activity measures to maximize supply chain performance. Journal of Accounting and Finance, 18(3), 80–94.
61.
LiaoY., HongP., & RaoS. S. (2010). Supply management, supply flexibility, and performance outcomes: An empirical investigation of manufacturing firms. Journal of Supply Chain Management, 46(3), 6–22.
62.
MalhotraN. K., & DashS. (2016). Marketing research (6th ed.). Pearson.
63.
MayA., AnslowA., WuY., OjiakoU., ChipuluM., & MarshallA. (2014). Prioritization of performance indicators in air cargo demand management: An Insight from Industry. Supply Chain Management: An International Journal, 19(1), 108–113.
64.
MehralianG., ZarenezhadF., & GhatariA. (2015). Developing a model for an agile supply chain in pharmaceutical industry. International Journal of Pharmaceutical and Healthcare Marketing, 9(1), 74–91.
65.
Ministry of Health and Family Welfare, GOI (2018). nnual Report of Department of Health and Family Welfare 2017-18. Ministry of Health and Family Welfare, Govt. of Indiahttps://www.mohfw.gov.in/
66.
MondalS. S., & PingaliV. (2017). Competition and intellectual property policies in the Indian pharmaceutical sector. Vikalpa, 42(2), 61–79.
67.
NaylorJ. B., NaimM. M., & BerryD. (1999). Legality: Integrating the lean and agile manufacturing paradigms in the total supply chain. International Journal of Production Economics, 62(1), 107–118.
68.
Organisation for Economic Co-operation and Development (2018). Research and development in the pharmaceutical sector, health at a glance 2018: OECD Indicators. OECD Publishing, Paris.
69.
PandaS. (2017). Influence of research and development (R&D) cost on profitability: A study of Indian pharmaceutical sector. Splint International Journal of Professionals, 4(1), 60–66.
70.
Pharmaceutical Export Promotion Council of India (2019). 15th annual report. Ministry of Commerce & Industry, Govt. of India.
71.
PilkingtonA., & FitzgeraldR. (2006). Operations management themes, concepts, and relationships: A forward retrospective of IJOPM. International Journal of Operations and Production Management, 26(11), 1255–1275.
72.
PilonF., & HadjieliasE. (2017). Strategic account management as a value co-creation selling model in the pharmaceutical industry. Journal of Business & Industrial Marketing, 32(2), 310–325.
73.
PiotrowiczW., & CuthbertsonR. (2015). Performance measurement and metrics in supply chains: an exploratory study. International Journal of Productivity and Performance Management, 64(8), 1068–1091.
74.
PohlenT. L., & ColemanB. J. (2005). Evaluating internal operations and supply chain performance using EVA and ABC. SAM Advanced Management Journal, 70(2), 45–58.
75.
PWC Report (2011). Indian Pharma Inc. Enhancing value through alliances and partnerships. Pharma Summit 2011. https://www.pwc.in/assets/pdfs/pharma/pwc-cii-pharma-summit-2011-v2.pdf
76.
RandallW. S., & Theodor FarrisM. (2009). Supply chain financing: Using cash-to-cash variables to strengthen the supply chain. International Journal of Physical Distribution & Logistics Management, 39(8), 669–689.
77.
RBI Bulletin (2017). Performance of Private Corporate Business Sector during First Half of 2016–17. Reserve Bank of India, Ministry of Finance, Government of India, 21–32.
78.
SaadM., & PatelB. (2006). An investigation of supply chain performance measurement in the Indian automotive sector. Benchmarking: An International Journal, 13(1/2), 36–53.
79.
SafaeiA.S., HusseiniS. M., FarahaniR. Z., JolaiF., & GhodsypourS. H. (2010). Integrated multi-site production-distribution planning in supply chain by hybrid modelling. International Journal of Production Research, 48(14), 4043–4069.
80.
SarangaH., & MoserR. (2010). Performance evaluation of purchasing and supply management using value chain DEA approach. European journal of operational research, 207(1), 197–205.
SellittoM. A., PereiraG. M., BorchardtM., Inacio da SilvaR., & ViegasC. V. (2014). A SCOR-based model for supply chain performance measurement: application in the footwear industry. International Journal of Production Research, 53(16), 4917–4926.
83.
SelviaridisK., & NorrmanA. (2014). Performance-based contracting in service supply chains: A service provider risk perspective. Supply Chain Management: An International Journal, 19(2), 153–172.
84.
ShahJ. (2016). Supply chain management. Text and cases (2nd ed.). Pearson
85.
ShahJ., & SinghN. (2001). Benchmarking Internal Supply Chain performance: Development of a Framework. The Journal of Supply Chain Management, 37(4), 37- 42.
86.
ShahN. (2004). Pharmaceutical supply chains: key issues and strategies for optimization. Computers and Chemical Engineering, 28(6–7), 929–941.
87.
SharmaC. (2012). R&D and firm performance: evidence from the Indian pharmaceutical industry. Journal of the Asia Pacific Economy, 17(2), 332–342.
88.
SilB. K. (2015). A comparative study of pre-and post-merger financial performances of selected pharmaceutical companies in India. IUP Journal of Business Strategy, 12(2), 8–53.
89.
SinghJ., & SinghP. (2013). Structure and growth performance of Indian pharmaceutical industry in the post-trips period: An empirical analysis. Journal of Economic Policy and Research, 9(1), 1–11.
90.
SinghR., KumarR., & KumarP. (2016). Strategic issues in pharmaceutical supply chains: A review. International Journal of Pharmaceutical and Healthcare Marketing, 10(3), 234–25.
91.
SmithK. L., & SmithD. (2008). Performance measures in supply chains. Australian Accounting Review, 15(35), 39–51.
92.
SultanaM. S., & ManivannanL. (2009). Knowledge management in pharmaceutical marketing: theoretical models. IUP Journal of Knowledge Management, 7(2), 62.
93.
SwinneyD. C. (2017). Pharmaceutical industry performance. In BhattacharyaS., MorrisonJ., MudraD., BenderD. (Eds.), Translating molecules into medicines. AAPS Advances in the Pharmaceutical Sciences Series (3–25). Springer.
94.
TalaveraM. G. V. (2015). Supply chain management practices and challenges: Case studies of four supply chains. Philippine Management Review, 22, 53–74.
95.
TripathiS., & TalukderB. (2020). Supply chain performance and profitability in Indian automobile industry: Evidence of segmental difference. Global Business Review. https://doi.org/10.1177/0972150919898302
96.
TripathiS., RangarajanK., & TalukderB. (2018). Benchmarking supply chain performance – A case study in Indian petroleum sector. Journal of Supply Chain Management System, 7(2), 8–25.
97.
TripathiS., RangarajanK., & TalukderB. (2019). Segmental differences in pharmaceutical industry and its impact on supply chain performance. International Journal of Pharmaceutical and Healthcare Marketing, 13(4), 516–540.
98.
TuckerJ., YakatanS., & YakatanS. (2008). Biogenerics 2007: How far have we come?. Journal of Commercial Biotechnology, 14(1), 56–64.
99.
TyagiS., NauriyalD. K., & GulatiR. (2018). Firm level R&D intensity: evidence from Indian drugs and pharmaceutical industry. Review of Managerial Science, 12(1), 167–202.
100.
VasilijevS., & PantelicD. (2010). Pharmaceutical market(ing): Theory and reality. Club of Economics in Miskolc’ TMP, 6(2), 85–91.
101.
VázquezX. H., SartalA., & Lozano-LozanoL.M. (2016). Watch the working capital of tier-two suppliers: a financial perspective of supply chain collaboration in the automotive industry. Supply Chain Management: An International Journal, 21(3), 321–333.
102.
WilkieD. C., JohnsonL. W., & WhiteL. (2012). Strategies used to defend pharmaceutical brands from generics. European Journal of Marketing, 46(9), 1195–1214.
103.
United Nations Conference on Trade and Development (2020). World investment report. UNCTAD. https://unctad.org/system/files/official-document/wir2020_en.pdf
104.
XieY., & BreenL. (2012). Greening community pharmaceutical supply chain in UK: A cross-boundary approach. Supply Chain Management: An International Journal, 7(1), pp.40–53.
105.
YousefiN., & AlibabaeiA. (2015). Information flow in the pharmaceutical supply chain. Iranian Journal of Pharmaceutical Research, 14(4), 1299–1303.
